引用本文:
【打印本页】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 3585次   下载 3222 本文二维码信息
码上扫一扫!
分享到: 微信 更多
卵巢恶性生殖细胞肿瘤行保留生育功能治疗的临床研究
张英丽, 陈鲁, 朱笕青, 羊正炎
浙江省肿瘤医院妇瘤科
摘要:
目的 分析卵巢恶性生殖细胞肿瘤(MOGCTs)患者行保留生育功能手术及化疗后的预后及妊娠生育情况。 方法 回 顾性分析 2003 年 1 月至 2010 年 12 月行保留生育功能手术的 31 例 MOGCTs 患者的临床病理资料及随访资料。 结果 31 例患者均 接受保留生育功能手术,术后接受了 1~6 个疗程辅助化疗,共随访 45~132 个月,中位随访时间 96 个月,2 例患者失访,3 例死亡,5 年累 积生存率为 83.6%。25 例停经患者中 22 例化疗后 6 个月内月经复潮,3 例 6 个月后月经复潮。2 例患儿发病时尚无初潮,化疗结束后未 影响月经初潮。停经患者停经期间血清黄体生成素(LH)升高至(61.8±11.3)mU/ml,促卵泡激素(FSH)明显升高至(89.7±40.2)mU/ml, 雌二醇(E2)水平降至(57.3±21.4)pg/ml,月经恢复后则恢复至正常水平,停经期间与月经复潮后比较均有统计学差异(均 P<0.05)。患者 妊娠 9 例,其中 7 例足月自然或剖宫产分娩,无一例发生早产或胎儿畸形;不孕症 6 例,7 例随访结束尚未婚,另 4 例已婚但目前无生育计 划。 结论 行保留生育功能手术的 MOGCTs 患者总体预后良好,化疗对患者月经的影响是可逆的,妊娠率有待进一步提高。
关键词:  卵巢肿瘤 肿瘤 生殖细胞和胚胎 保留生育功能手术 预后 妊娠
DOI:
分类号:
基金项目:浙江省医药卫生科技项目
Fertility-sparing surgery for malignant ovarian germ cell tumors
ZHANG Yingli, CHEN Lu, ZHU jianqin, YANG Zhengyan
Zhejiang Cancer Hospital
Abstract:
Objective To evaluate the clinical outcomes of patients with malignant ovarian germ cell tumors (MOGCTs) undergoing fertility-sparing surgery. Methods Totally 31 MOGCTs patients underwent fertility-sparing surgery in our hospital between January 2003 and December 2010. The clinical-pathological and follow-up data were retrospectively analyzed. Results All these 31 MOGCTs patients received fertility-sparing surgery followed by 1~6 courses of BEP/BVP/TP chemotherapy. Patients were followed-up for 45~132 months after surgery with a mean follow-up time of 96 months; 2 patients were lost to follow-up and 3 died of the disease. The five-year cumulative survival rate was 83.6% . Among 25 patients with chemotherapy-related amenorrhea, 22 resumed menstruation within 6 months after chemotherapy and 3 after 6 months; while menstruation was not affected in 2 patients, who got the disease during childhood. During the amenorrhea period of patients, the serum LH and FSH levels rose to(61.8±11.3)mU/ml and(89.7±40.2)mU/ml, respectively(P<0.05), and E2 level decreased to(57.3±21.4)pg/ml(P<0.05); then returned to normal levels after menstruation recovery. Among these patients, 9 had pregnancies, 7 of whom delivered healthy babies; 6 were infertility, 7 were unmarried, and other 4 patients were married but had no desire of pregnancy. Conclusion Fertility-sparing surgery followed by adjuvant chemotherapy can achieve satisfactory effectiveness for MOGCTs. The effect of chemotherapy on menstruation is reversible and the pregnancy rate should be increased in the future.
Key words:  Ovarian neoplasms Neoplasms Germ cell and embryonal Fertility-sparing surgery Prognosis Pregnancy